Navamedic ASA
Lars Hjarrand currently serves as Chief Financial Officer at Navamedic ASA since December 2019, bringing extensive financial leadership experience from previous roles including CFO for the Nordic Region at Lowell and CFO at Remco. Additionally, Lars has held multiple positions at Lindorff, including Interim CFO for the Lindorff Group, and served as Corporate Controller. Earlier career highlights include being Chief Group Controller at Tandberg Data and Manager in Strategic Finance at Lawson Software. Lars began the career as a Financial Analyst at Medtronic and later as a Sr Financial Analyst at Ecolab. Academic qualifications include an MBA in Finance from the University of Minnesota - Carlson School of Management, and a Bachelor's degree in Economics from the University of Minnesota.
This person is not in any teams
Navamedic ASA
Navamedic is a reliable supplier of high-quality products, delivered to hospitals and through pharmacies, meeting the specific medical needs of patients and consumers. Our product portfolio consists of prescription and OTC pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. Navamedic is present in all Nordic countries, the Baltics and Benelux and has sales of specific products even in other European countries like UK and Greece. Our headquarter is in Oslo, Norway and we are listed on the Oslo Stock Exchange (ticker: NAVA). We are about 30 highly qualified employees with strong competence in regulatory affairs, quality assurance, reimbursement, marketing and sales and thus a full-service provider securing market access through our local competence.